Sector: Health Care
Director information for HOLOGIC INC (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMY M. WENDELL | Lead Independent Director; Former Senior Vice President, Strategy & BD&L Covidien plc | 64 | ["expertise in mergers and acquisitions", "portfolio management", "resource allocation", "identification of new market opportunities", "knowledge of developed and emerging markets", "expertise in early-stage technologies", "Senior Advisor for Perella Weinberg Partners", "Senior Advisor for McKinsey\u2019s Strategy and Corporate Finance Practice", "various roles at Covidien plc including Senior Vice President of Strategy and Business Development"] | ["Compensation", "Nominating and Corporate Governance", "Lead Independent Director", "Nominating and Corporate Governance (CHAIR)", "Audit and Finance"] | 2025 |
| Brandon Schnittker | Division President, GYN Surgical Solutions | 41 | ["Promoted to Division President, GYN Surgical Solutions in January 2024", "Joined Hologic in May 2022 as Vice President, Surgical Sales", "16 years of experience at Stryker in roles of increasing responsibility", "Director of Marketing for Stryker ENT from 2016 to early 2022", "Bachelor of Science degree from The Ohio State University", "MBA from the University of North Carolina\u2019s Kenan-Flagler Business School"] | [] | 2025 |
| CHARLES J. DOCKENDORFF | Director; Former Chief Financial Officer and Executive Vice President Covidien plc | 70 | ["Extensive experience with financial accounting matters for complex global healthcare organizations", "Substantial experience overseeing financial reporting processes of large public companies", "Strong track record of value creation", "Depth of experience in operations and strategy", "Former Executive Vice President and Chief Financial Officer of Covidien plc", "CFO at Covidien and Tyco Healthcare from 1995 to 2015", "Joined Kendall Healthcare Products Company in 1989 as Controller", "Vice President and Controller of Kendall/Tyco Healthcare in 1994", "Prior CFO of Epsco Inc. and Infrared Industries, Inc.", "Worked as an accountant for Arthur Young & Company and General Motors Corporation", "Bachelor\u2019s degree in accounting from the University of Massachusetts at Amherst", "Master of Science in finance from Bentley College"] | ["Audit and Finance", "Audit and Finance (CHAIR)"] | 2025 |
| Christiana Stamoulis | Executive Vice President and Chief Financial Officer Incyte Corporation; Director | 54 | ["Strength in strategy and corporate finance", "Experience in executing initiatives for growth in the medical products field and related industries", "Unique perspective on financial and capital markets operations", "Director at Incyte Corporation", "Former Chief Financial Officer of Unum Therapeutics", "Independent advisor to biopharmaceutical companies", "Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals", "Managing Director in Investment Banking at Citigroup", "Investment banking career at Goldman Sachs & Co.", "Strategy consultant at The Boston Consulting Group", "Bachelor of Science in economics and architecture from MIT", "MBA from MIT Sloan School of Management"] | ["Audit and Finance"] | 2025 |
| Dr. Schneiders | President, Diagnostic Solutions | ["Ph.D. in biochemistry from Boston College", "Bachelor\u2019s degree in biochemistry from Trinity College", "Experience in various roles since 1998", "Held positions including Vice President, U.S. Sales and Commercial Excellence and Vice President, Diagnostic Laboratory Solutions"] | [] | 2025 | |
| Jan Verstreken | Group President, International | 57 | ["more than 25 years of experience primarily at Teleflex", "served as President of Asia Pacific (APAC) for Teleflex from 2013 to 2016", "Regional Vice President and General Manager, EMEA from 2009 to 2013", "co-founded Access Medical SA", "Bachelor of Marketing degree from the Hoger Handels Instituut in Turnhout, Belgium", "completed leadership coursework at the Thunderbird School of Global Management and the Levinson Institute at Harvard"] | [] | 2025 |
| Karleen M. Oberton | Chief Financial Officer | 55 | ["Joined Hologic in 2006 as corporate controller", "Promoted to Chief Accounting Officer in 2015", "Senior corporate controller of Immunogen from 2004 to 2006", "Audit Senior Manager in Ernst & Young\u2019s Life Science practice", "Audit Senior Manager in Arthur Andersen\u2019s High Technology practice", "Certified Public Accountant for more than 18 years", "Bachelor of Science in Business Administration from Merrimack College"] | ["Merrimack College\u2019s Leadership Council"] | 2025 |
| Ludwig N. Hantson | Former Chief Executive Officer Alexion Pharmaceuticals, Inc.; Director | 62 | ["Over 30 years of experience in the biopharmaceutical industry", "Former CEO of Alexion Pharmaceuticals, Inc.", "Former President and CEO of Baxalta Incorporated", "Led Baxalta\u2019s successful spin-off from Baxter International Inc.", "Held leadership roles at Novartis AG, including CEO of Pharma North America", "Spent 13 years with Johnson & Johnson in marketing and R&D", "Ph.D. in motor rehabilitation and physical therapy from University of Louvain"] | ["Compensation", "Nominating and Corporate Governance", "Audit and Finance"] | 2025 |
| Mark Horvath | Division President, Breast and Skeletal Health Solutions | 62 | ["Promoted to Division President in January 2025", "Joined Hologic in September 2020 as Vice President, Service Operations", "Promoted to Corporate Vice President of Global Services in 2022", "Over 20 years at Stryker in various positions including Vice President, Global Customer Care", "Holds a bachelor\u2019s degree in economics from McMaster University", "Completed leadership coursework at Harvard Business School"] | [] | 2025 |
| Martin Madaus | Operating Executive Carlyle Group; Operating Executive to the Carlyle Group; Director | 65 | ["Deep industry, technical, business and international experiences", "Strong leadership background", "Former Chief Operations Officer at Sherlock Biosciences, Inc.", "Former Chairman and Chief Executive Officer at OrthoClinical Diagnostics, Inc.", "Former Chairman, President and Chief Executive Officer of Millipore Corporation", "Doctor of Veterinary Medicine from the University of Munich", "Ph.D. in Veterinary Medicine from the Veterinary School of Hanover"] | ["Compensation", "Nominating and Corporate Governance", "Audit and Finance"] | 2025 |
| Nanaz Mohtashami | Managing Director Russell Reynolds Associates | 47 | ["Background in global strategy", "Experience in the broader healthcare sector", "Strong team orientation", "Managing Director at Russell Reynolds Associates", "Country Manager for the UK", "Head of global Med Tech, Devices & Diagnostics Practice", "Handled leadership assignments at executive and non-executive levels", "13 years as a strategy consultant with Monitor Group", "BA and M.Eng. from Cambridge University", "MBA from INSEAD"] | ["Compensation", "Nominating and Corporate Governance", "Audit and Finance"] | 2025 |
| Sally W. Crawford | Director | 71 | [] | ["Audit and Finance", "Compensation"] | 2025 |
| Scott T. Garrett | Director | 74 | [] | ["Compensation"] | 2025 |
| Stacey D. Stewart | Chief Executive Officer Mothers Against Drunk Driving; Director | 60 | ["deep expertise as an executive leading large purpose-driven organizations", "background in finance", "valuable knowledge and perspective on healthcare, policy, and health equity", "previously served as President & CEO of March of Dimes Inc.", "served in a variety of executive positions at United Way Worldwide", "senior vice president of Fannie Mae", "holds a Bachelor of Arts from Georgetown University", "holds a Master of Business Administration from the University of Michigan"] | ["Audit and Finance"] | 2025 |
| Stephen P. MacMillan | Chairman, President and Chief Executive Officer Hologic, Inc.; Chairman of the Board | 61 | ["Direct responsibility for the Company\u2019s strategy and operations", "Led the Company through a period of transformation during the COVID-19 pandemic", "Previous roles at sBioMed, LLC, Stryker Corporation, and Pharmacia Corporation", "Experience at Johnson & Johnson and Procter & Gamble", "Bachelor of Arts degree in economics from Davidson College", "Graduate of Harvard Business School\u2019s Advanced Management Program"] | [] | 2025 |
